BARINTHUS BIOTHERAPEUTICS PLC — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
R&D↓-52.7% -$4M
$4M
D&A↓-36.3% -$519K
$909K
Operating Income↓-60.6% -$6M
$-15M
EBITDA↓-36.3% -$519K
$909K
Interest Expense↑+8.3% +$1K
$13K
Interest Income↓-36.3% -$231K
$406K
Other Income/Expense↓-105.5% -$669K
$-35K
Pretax Income↓-80.1% -$7M
$-15M
Tax Provision↓-2266.7% -$68K
$-71K
Net Income↓-79.5% -$6M
$-15M
Operating Margin
-62.7%
Net Margin
-54.2%
Effective Tax Rate↑+0.4pts
0.5%
Deferred Tax Assets
—
Deferred Tax Liabilities
$254K
ETR (Continuing Operations)↑+0.2pts
0.3%
ETR Federal Statutory↑+0.0pts
25.0%
ETR Foreign Differential (pp)
1.2%
Operating Lease Cost↓-37.3% -$133K
$224K
Revenue YoY Variation
-100.0%
Income YoY Variation↓-102.4pts
-60.6%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↓-13.3pts
35.4%